Positions

Selected Publications

Academic Article

Year Title Altmetric
2018 Current Evidence in Delivery and Therapeutic Uses of Fecal Microbiota Transplantation in Human Diseases—Clostridium difficile Disease and BeyondAmerican Journal of the Medical Sciences.  356:424-432. 2018
2018 Exercises in Clinical Reasoning: Take a Time-Out and ReflectJournal of General Internal Medicine.  33:388-392. 2018
2016 Letter: a simple out-patient faecal microbiota transplant techniqueAlimentary Pharmacology and Therapeutics.  44:101. 2016
2006 Primary hepatic non-hodgkin lymphoma in an HIV-infected patientInfections in Medicine.  23:174. 2006

Investigator On

  • Dalbavancin as an Option for Treatment of S. aureus Bacteremia (DOTS): A Phase 2b, Multicenter, Randomized, Open-Label, Assessor-Blinded Superiority Study to Compare the Efficacy and Safety of Dalbavancin to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients with Complicated S. aureus Bacteremia  awarded by Duke University 2020 - 2026
  • The Natural History of Antifungal Failure in Invasive Candidiasis in the United States  awarded by UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER (HOUSTON) 2020 - 2022
  • Private Grant  awarded by HOOKIPA BIOTECH 2019 - 2022
  • Private Grant  awarded by MAYNE PHARMA INC 2018 - 2022
  • A Phase 2 Proof-of-concept Study to Evaluate the Efficacy and Safety of MEDI3902 in Mechanically Ventilated Patients for the Prevention of Nosocomial Pneumonia Caused by Pseudomonas aeruginosa  awarded by DUKE CLINICAL RESEARCH INSTITUTE 2018 - 2022
  • Private Grant  awarded by CIDARA THERAPEUTICS, INC. - NEW 2018 - 2021
  • Private Grant  awarded by SCYNEXIS 2017 - 2021
  • Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) COVID 19 SUPPLEMENT  awarded by Emory University 2020 - 2021
  • High VS. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients  awarded by VANDERBILT UNIVERSITY 2017 - 2021
  • Consortium on Resistance Against Carbapenems in Klebsiella pneumoniae and Other Enterobacteriaceae (CRACKLE): a Prospective, Observational Cohort Study  awarded by Duke University 2017 - 2020
  • Private Grant  awarded by CIDARA THERAPEUTICS, INC. - NEW 2016 - 2020
  • Private Grant  awarded by AMPLYX PHARMACEUTICALS INC 2018 - 2020
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2013 - 2019
  • UAB Public Health/Biomedical Research Training Program  awarded by NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES/NIH/DHHS 2014 - 2019
  • Private Grant  awarded by T2 BIOSYSTEMS 2016 - 2018
  • Private Grant  awarded by IMMUNO-MYCOLOGICS, INC. 2015 - 2018
  • Private Grant  awarded by SCYNEXIS 2014 - 2016
  • Kaizen-ME: A Novel Gamification-lnfused Education Platform for Millennial Learners  awarded by UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION 2013 - 2016
  • Private Grant  awarded by T2 BIOSYSTEMS 2014 - 2016
  • Private Grant  awarded by T2 BIOSYSTEMS 2012 - 2015
  • Prospective Observational Evaluation of the Association Between the Day 2 Vancomycin Exposure and Failure Rates Among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE)  awarded by Duke University 2014
  • Private Grant  awarded by CEREXA, INC. 2013 - 2014
  • Education And Training

  • Doctor of Medicine, 1998
  • UAB Hospital, Residency 2003
  • Massachusetts General Hospital, Postdoctoral Fellowship 2005
  • Full Name

  • Martin Rodriguez